Global Human Injection Flu Vaccine Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Injection Flu Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Human Injection Flu Vaccine, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.In 2024, global Human Injection Flu Vaccine production reached approximately 842 m units, with an average global market price of around US$ 10.8 per unit.The average gross profit margin for this product is 57% and capacity is about 900 million units.Institutionalization of respiratory vaccination programs and heightened public awareness of respiratory disease prevention have created structural demand expansion for human injection flu vaccines. Major vaccine manufacturers repeatedly emphasize seasonal supply readiness and logistics planning in their annual reports, indicating predictable procurement cycles and policy backing. Concurrently, new production platforms?cell-based, recombinant, and mRNA?offer operational efficiencies and product differentiation that enable premium branding and strategic partnerships. Government investments in domestic manufacturing and cold-chain infrastructure further advance localized, sustainable supply chains and provide long-term institutional support for market growth. Structural uncertainty arises from influenza?s high mutation rate, annual strain-matching risks, and the seasonality and inventory complexity of vaccine manufacturing. Company reports and regulatory communications show elevated compliance and quality assurance costs amid advancing technologies and regulatory scrutiny. Additional headwinds include persistent public scrutiny over vaccine safety and efficacy, market sentiment sensitivity to supply or efficacy signals, and regulatory evaluation differences across technology platforms (e.g., mRNA vs. traditional), all of which can perturb commercial timelines and confidence in the near term. Demand is shifting from one-off seasonal uptake toward routine, stratified vaccination strategies: employer and institutional health programs are embedding influenza vaccines into annual plans while aging and chronic-disease populations increase demand for higher-efficacy products. Expansion of retail pharmacy and primary-care vaccination services diversifies access channels. Public health recommendations and national immunization policies continue to shape provider behavior and individual uptake, establishing a stable and scalable demand foundation. Upstream for injection flu vaccines includes antigen sources (eggs or cell substrates), specialized culture media, adjuvants, purification reagents, sterile single-use consumables, and cold-chain logistics. Annual reports indicate reduced dependence on egg-based supply as cell-based and recombinant methods scale, but a corresponding rise in demand for high-quality media, dedicated purification consumables, and auditable raw materials. For mRNA approaches, nucleotide synthesis, lipid nanoparticle carriers, and their QC systems emerge as critical upstream nodes, pushing suppliers toward deep specialization. Regulatory emphasis on traceability, animal-free components, and biosafety is accelerating supply-chain standardization and resilience.
The global Human Injection Flu Vaccine market size was estimated at USD 8434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Injection Flu Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Injection Flu Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Injection Flu Vaccine market.
Global Human Injection Flu Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Injection Flu Vaccine Market
Overview of the regional outlook of the Human Injection Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Injection Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Injection Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Human Injection Flu Vaccine market size was estimated at USD 8434.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Human Injection Flu Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Human Injection Flu Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Human Injection Flu Vaccine market.
Global Human Injection Flu Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Market Segmentation (by Type)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Segmentation (by Application)
6 Months to 3 Years
> 3 Years
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Human Injection Flu Vaccine Market
Overview of the regional outlook of the Human Injection Flu Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Injection Flu Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Injection Flu Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Injection Flu Vaccine
1.2 Key Market Segments
1.2.1 Human Injection Flu Vaccine Segment by Type
1.2.2 Human Injection Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN INJECTION FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Injection Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Injection Flu Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN INJECTION FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Injection Flu Vaccine Product Life Cycle
3.3 Global Human Injection Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Injection Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Injection Flu Vaccine Market Competitive Situation and Trends
3.8.1 Human Injection Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Injection Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN INJECTION FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Injection Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN INJECTION FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Injection Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Injection Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 HUMAN INJECTION FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Human Injection Flu Vaccine Market Size by Type (2020-2025)
6.4 Global Human Injection Flu Vaccine Price by Type (2020-2025)
7 HUMAN INJECTION FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Injection Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global Human Injection Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 HUMAN INJECTION FLU VACCINE MARKET SALES BY REGION
8.1 Global Human Injection Flu Vaccine Sales by Region
8.1.1 Global Human Injection Flu Vaccine Sales by Region
8.1.2 Global Human Injection Flu Vaccine Sales Market Share by Region
8.2 Global Human Injection Flu Vaccine Market Size by Region
8.2.1 Global Human Injection Flu Vaccine Market Size by Region
8.2.2 Global Human Injection Flu Vaccine Market Size by Region
8.3 North America
8.3.1 North America Human Injection Flu Vaccine Sales by Country
8.3.2 North America Human Injection Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Injection Flu Vaccine Sales by Country
8.4.2 Europe Human Injection Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Injection Flu Vaccine Sales by Region
8.5.2 Asia Pacific Human Injection Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Injection Flu Vaccine Sales by Country
8.6.2 South America Human Injection Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Injection Flu Vaccine Sales by Region
8.7.2 Middle East and Africa Human Injection Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN INJECTION FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Injection Flu Vaccine by Region(2020-2025)
9.2 Global Human Injection Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Injection Flu Vaccine Production
9.4.1 North America Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Injection Flu Vaccine Production
9.5.1 Europe Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Injection Flu Vaccine Production (2020-2025)
9.6.1 Japan Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Injection Flu Vaccine Production (2020-2025)
9.7.1 China Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Human Injection Flu Vaccine Product Overview
10.1.3 Sanofi Human Injection Flu Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Human Injection Flu Vaccine Product Overview
10.2.3 CSL Human Injection Flu Vaccine Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Human Injection Flu Vaccine Product Overview
10.3.3 GSK Human Injection Flu Vaccine Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Human Injection Flu Vaccine Product Overview
10.4.3 Viatris Human Injection Flu Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Human Injection Flu Vaccine Product Overview
10.5.3 AstraZeneca Human Injection Flu Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Human Injection Flu Vaccine Product Overview
10.6.3 Hualan Bio Human Injection Flu Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
10.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Human Injection Flu Vaccine Product Overview
10.8.3 Sinovac Human Injection Flu Vaccine Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 BCHT
10.9.1 BCHT Basic Information
10.9.2 BCHT Human Injection Flu Vaccine Product Overview
10.9.3 BCHT Human Injection Flu Vaccine Product Market Performance
10.9.4 BCHT Business Overview
10.9.5 BCHT Recent Developments
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Basic Information
10.10.2 Jiangsu GDK Human Injection Flu Vaccine Product Overview
10.10.3 Jiangsu GDK Human Injection Flu Vaccine Product Market Performance
10.10.4 Jiangsu GDK Business Overview
10.10.5 Jiangsu GDK Recent Developments
10.11 KM Biologics
10.11.1 KM Biologics Basic Information
10.11.2 KM Biologics Human Injection Flu Vaccine Product Overview
10.11.3 KM Biologics Human Injection Flu Vaccine Product Market Performance
10.11.4 KM Biologics Business Overview
10.11.5 KM Biologics Recent Developments
11 HUMAN INJECTION FLU VACCINE MARKET FORECAST BY REGION
11.1 Global Human Injection Flu Vaccine Market Size Forecast
11.2 Global Human Injection Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Injection Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region
11.2.4 South America Human Injection Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Injection Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Injection Flu Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Injection Flu Vaccine by Type (2026-2035)
12.1.2 Global Human Injection Flu Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Injection Flu Vaccine by Type (2026-2035)
12.2 Global Human Injection Flu Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Injection Flu Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Injection Flu Vaccine
1.2 Key Market Segments
1.2.1 Human Injection Flu Vaccine Segment by Type
1.2.2 Human Injection Flu Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN INJECTION FLU VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Injection Flu Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Human Injection Flu Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN INJECTION FLU VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Human Injection Flu Vaccine Product Life Cycle
3.3 Global Human Injection Flu Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Human Injection Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Human Injection Flu Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Human Injection Flu Vaccine Market Competitive Situation and Trends
3.8.1 Human Injection Flu Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Human Injection Flu Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HUMAN INJECTION FLU VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Injection Flu Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN INJECTION FLU VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Human Injection Flu Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Human Injection Flu Vaccine Market
5.7 ESG Ratings of Leading Companies
6 HUMAN INJECTION FLU VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Human Injection Flu Vaccine Market Size by Type (2020-2025)
6.4 Global Human Injection Flu Vaccine Price by Type (2020-2025)
7 HUMAN INJECTION FLU VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Injection Flu Vaccine Market Sales by Application (2020-2025)
7.3 Global Human Injection Flu Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
8 HUMAN INJECTION FLU VACCINE MARKET SALES BY REGION
8.1 Global Human Injection Flu Vaccine Sales by Region
8.1.1 Global Human Injection Flu Vaccine Sales by Region
8.1.2 Global Human Injection Flu Vaccine Sales Market Share by Region
8.2 Global Human Injection Flu Vaccine Market Size by Region
8.2.1 Global Human Injection Flu Vaccine Market Size by Region
8.2.2 Global Human Injection Flu Vaccine Market Size by Region
8.3 North America
8.3.1 North America Human Injection Flu Vaccine Sales by Country
8.3.2 North America Human Injection Flu Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Human Injection Flu Vaccine Sales by Country
8.4.2 Europe Human Injection Flu Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Human Injection Flu Vaccine Sales by Region
8.5.2 Asia Pacific Human Injection Flu Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Human Injection Flu Vaccine Sales by Country
8.6.2 South America Human Injection Flu Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Human Injection Flu Vaccine Sales by Region
8.7.2 Middle East and Africa Human Injection Flu Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HUMAN INJECTION FLU VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Injection Flu Vaccine by Region(2020-2025)
9.2 Global Human Injection Flu Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Human Injection Flu Vaccine Production
9.4.1 North America Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Human Injection Flu Vaccine Production
9.5.1 Europe Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Human Injection Flu Vaccine Production (2020-2025)
9.6.1 Japan Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Human Injection Flu Vaccine Production (2020-2025)
9.7.1 China Human Injection Flu Vaccine Production Growth Rate (2020-2025)
9.7.2 China Human Injection Flu Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Human Injection Flu Vaccine Product Overview
10.1.3 Sanofi Human Injection Flu Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Human Injection Flu Vaccine Product Overview
10.2.3 CSL Human Injection Flu Vaccine Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Human Injection Flu Vaccine Product Overview
10.3.3 GSK Human Injection Flu Vaccine Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Human Injection Flu Vaccine Product Overview
10.4.3 Viatris Human Injection Flu Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Human Injection Flu Vaccine Product Overview
10.5.3 AstraZeneca Human Injection Flu Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Human Injection Flu Vaccine Product Overview
10.6.3 Hualan Bio Human Injection Flu Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
10.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Human Injection Flu Vaccine Product Overview
10.8.3 Sinovac Human Injection Flu Vaccine Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 BCHT
10.9.1 BCHT Basic Information
10.9.2 BCHT Human Injection Flu Vaccine Product Overview
10.9.3 BCHT Human Injection Flu Vaccine Product Market Performance
10.9.4 BCHT Business Overview
10.9.5 BCHT Recent Developments
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Basic Information
10.10.2 Jiangsu GDK Human Injection Flu Vaccine Product Overview
10.10.3 Jiangsu GDK Human Injection Flu Vaccine Product Market Performance
10.10.4 Jiangsu GDK Business Overview
10.10.5 Jiangsu GDK Recent Developments
10.11 KM Biologics
10.11.1 KM Biologics Basic Information
10.11.2 KM Biologics Human Injection Flu Vaccine Product Overview
10.11.3 KM Biologics Human Injection Flu Vaccine Product Market Performance
10.11.4 KM Biologics Business Overview
10.11.5 KM Biologics Recent Developments
11 HUMAN INJECTION FLU VACCINE MARKET FORECAST BY REGION
11.1 Global Human Injection Flu Vaccine Market Size Forecast
11.2 Global Human Injection Flu Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Injection Flu Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region
11.2.4 South America Human Injection Flu Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Human Injection Flu Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Human Injection Flu Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Human Injection Flu Vaccine by Type (2026-2035)
12.1.2 Global Human Injection Flu Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Human Injection Flu Vaccine by Type (2026-2035)
12.2 Global Human Injection Flu Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Injection Flu Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Injection Flu Vaccine Market Size by Type (M USD)
Table 4. Global Human Injection Flu Vaccine Market Size by Application
Table 5. Human Injection Flu Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Human Injection Flu Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Injection Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2025)
Table 11. Global Market Human Injection Flu Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Injection Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Injection Flu Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Injection Flu Vaccine Sales by Type (K MT)
Table 27. Global Human Injection Flu Vaccine Market Size by Type (M USD)
Table 28. Global Human Injection Flu Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Human Injection Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Injection Flu Vaccine Market Share by Type (2020-2025)
Table 32. Global Human Injection Flu Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Injection Flu Vaccine Sales (K MT) by Application
Table 34. Global Human Injection Flu Vaccine Market Size by Application
Table 35. Global Human Injection Flu Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Human Injection Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Injection Flu Vaccine Market Share by Application (2020-2025)
Table 39. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Injection Flu Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Injection Flu Vaccine Market Size by Region (2020-2025)
Table 44. North America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Injection Flu Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Human Injection Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Injection Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Human Injection Flu Vaccine Product Overview
Table 64. Sanofi Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Human Injection Flu Vaccine Product Overview
Table 70. CSL Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Human Injection Flu Vaccine Product Overview
Table 76. GSK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Human Injection Flu Vaccine Product Overview
Table 82. Viatris Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Human Injection Flu Vaccine Product Overview
Table 87. AstraZeneca Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Human Injection Flu Vaccine Product Overview
Table 92. Hualan Bio Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. Changchun Institute of Biological Basic Information
Table 96. Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
Table 97. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Changchun Institute of Biological Business Overview
Table 99. Changchun Institute of Biological Recent Developments
Table 100. Sinovac Basic Information
Table 101. Sinovac Human Injection Flu Vaccine Product Overview
Table 102. Sinovac Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinovac Business Overview
Table 104. Sinovac Recent Developments
Table 105. BCHT Basic Information
Table 106. BCHT Human Injection Flu Vaccine Product Overview
Table 107. BCHT Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. BCHT Business Overview
Table 109. BCHT Recent Developments
Table 110. Jiangsu GDK Basic Information
Table 111. Jiangsu GDK Human Injection Flu Vaccine Product Overview
Table 112. Jiangsu GDK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jiangsu GDK Business Overview
Table 114. Jiangsu GDK Recent Developments
Table 115. KM Biologics Basic Information
Table 116. KM Biologics Human Injection Flu Vaccine Product Overview
Table 117. KM Biologics Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. KM Biologics Business Overview
Table 119. KM Biologics Recent Developments
Table 120. Global Human Injection Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Human Injection Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Human Injection Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Human Injection Flu Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Human Injection Flu Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Human Injection Flu Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Human Injection Flu Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Human Injection Flu Vaccine Market Size by Type (M USD)
Table 4. Global Human Injection Flu Vaccine Market Size by Application
Table 5. Human Injection Flu Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Human Injection Flu Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Human Injection Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Human Injection Flu Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Human Injection Flu Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Injection Flu Vaccine as of 2025)
Table 11. Global Market Human Injection Flu Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Human Injection Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Injection Flu Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Human Injection Flu Vaccine Sales by Type (K MT)
Table 27. Global Human Injection Flu Vaccine Market Size by Type (M USD)
Table 28. Global Human Injection Flu Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Human Injection Flu Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Human Injection Flu Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Human Injection Flu Vaccine Market Share by Type (2020-2025)
Table 32. Global Human Injection Flu Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Human Injection Flu Vaccine Sales (K MT) by Application
Table 34. Global Human Injection Flu Vaccine Market Size by Application
Table 35. Global Human Injection Flu Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Human Injection Flu Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Human Injection Flu Vaccine Market Share by Application (2020-2025)
Table 39. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Human Injection Flu Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Human Injection Flu Vaccine Market Size by Region (2020-2025)
Table 44. North America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Human Injection Flu Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Human Injection Flu Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Human Injection Flu Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Human Injection Flu Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Human Injection Flu Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Human Injection Flu Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Human Injection Flu Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Human Injection Flu Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Human Injection Flu Vaccine Product Overview
Table 64. Sanofi Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Human Injection Flu Vaccine Product Overview
Table 70. CSL Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Human Injection Flu Vaccine Product Overview
Table 76. GSK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Viatris Basic Information
Table 81. Viatris Human Injection Flu Vaccine Product Overview
Table 82. Viatris Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Viatris Business Overview
Table 84. Viatris Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Human Injection Flu Vaccine Product Overview
Table 87. AstraZeneca Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Hualan Bio Basic Information
Table 91. Hualan Bio Human Injection Flu Vaccine Product Overview
Table 92. Hualan Bio Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Hualan Bio Business Overview
Table 94. Hualan Bio Recent Developments
Table 95. Changchun Institute of Biological Basic Information
Table 96. Changchun Institute of Biological Human Injection Flu Vaccine Product Overview
Table 97. Changchun Institute of Biological Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Changchun Institute of Biological Business Overview
Table 99. Changchun Institute of Biological Recent Developments
Table 100. Sinovac Basic Information
Table 101. Sinovac Human Injection Flu Vaccine Product Overview
Table 102. Sinovac Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinovac Business Overview
Table 104. Sinovac Recent Developments
Table 105. BCHT Basic Information
Table 106. BCHT Human Injection Flu Vaccine Product Overview
Table 107. BCHT Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. BCHT Business Overview
Table 109. BCHT Recent Developments
Table 110. Jiangsu GDK Basic Information
Table 111. Jiangsu GDK Human Injection Flu Vaccine Product Overview
Table 112. Jiangsu GDK Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Jiangsu GDK Business Overview
Table 114. Jiangsu GDK Recent Developments
Table 115. KM Biologics Basic Information
Table 116. KM Biologics Human Injection Flu Vaccine Product Overview
Table 117. KM Biologics Human Injection Flu Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. KM Biologics Business Overview
Table 119. KM Biologics Recent Developments
Table 120. Global Human Injection Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Human Injection Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Human Injection Flu Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Human Injection Flu Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Human Injection Flu Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Human Injection Flu Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Human Injection Flu Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Human Injection Flu Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Human Injection Flu Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Human Injection Flu Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Human Injection Flu Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Injection Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Injection Flu Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Human Injection Flu Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Human Injection Flu Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Injection Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Injection Flu Vaccine Product Life Cycle
Figure 13. Human Injection Flu Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Human Injection Flu Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Injection Flu Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Injection Flu Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Human Injection Flu Vaccine
Figure 19. Global Human Injection Flu Vaccine Market PEST Analysis
Figure 20. Global Human Injection Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Injection Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of Human Injection Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Human Injection Flu Vaccine by Type in 2025
Figure 29. Market Share of Human Injection Flu Vaccine by Type (2020-2025)
Figure 30. Market Share of Human Injection Flu Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Injection Flu Vaccine Market Share by Application
Figure 33. Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Human Injection Flu Vaccine Sales Market Share by Application in 2025
Figure 35. Global Human Injection Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global Human Injection Flu Vaccine Market Share by Application in 2025
Figure 37. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Injection Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Human Injection Flu Vaccine Market Size by Region (2020-2025)
Figure 40. North America Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Injection Flu Vaccine Market Size by Country in 2024
Figure 45. U.S. Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Injection Flu Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Injection Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Injection Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Injection Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Injection Flu Vaccine Market Size by Country in 2024
Figure 55. Germany Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Injection Flu Vaccine Market Size by Region in 2024
Figure 68. China Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America Human Injection Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Human Injection Flu Vaccine Market Size by Country in 2024
Figure 82. Brazil Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Injection Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Injection Flu Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Injection Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Injection Flu Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Injection Flu Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Injection Flu Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Injection Flu Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Human Injection Flu Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Human Injection Flu Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Injection Flu Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Human Injection Flu Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Human Injection Flu Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Injection Flu Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Human Injection Flu Vaccine Product Life Cycle
Figure 13. Human Injection Flu Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Human Injection Flu Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Human Injection Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Human Injection Flu Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Human Injection Flu Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Human Injection Flu Vaccine
Figure 19. Global Human Injection Flu Vaccine Market PEST Analysis
Figure 20. Global Human Injection Flu Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Human Injection Flu Vaccine Market Share by Type
Figure 27. Sales Market Share of Human Injection Flu Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Human Injection Flu Vaccine by Type in 2025
Figure 29. Market Share of Human Injection Flu Vaccine by Type (2020-2025)
Figure 30. Market Share of Human Injection Flu Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Human Injection Flu Vaccine Market Share by Application
Figure 33. Global Human Injection Flu Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Human Injection Flu Vaccine Sales Market Share by Application in 2025
Figure 35. Global Human Injection Flu Vaccine Market Share by Application (2020-2025)
Figure 36. Global Human Injection Flu Vaccine Market Share by Application in 2025
Figure 37. Global Human Injection Flu Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Human Injection Flu Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Human Injection Flu Vaccine Market Size by Region (2020-2025)
Figure 40. North America Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 43. North America Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Human Injection Flu Vaccine Market Size by Country in 2024
Figure 45. U.S. Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Human Injection Flu Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Human Injection Flu Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Human Injection Flu Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Human Injection Flu Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Human Injection Flu Vaccine Market Size by Country in 2024
Figure 55. Germany Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Human Injection Flu Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Human Injection Flu Vaccine Market Size by Region in 2024
Figure 68. China Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Human Injection Flu Vaccine Sales Market Share by Country in 2024
Figure 80. South America Human Injection Flu Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Human Injection Flu Vaccine Market Size by Country in 2024
Figure 82. Brazil Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Human Injection Flu Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Human Injection Flu Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Human Injection Flu Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Human Injection Flu Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Human Injection Flu Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Human Injection Flu Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Human Injection Flu Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Human Injection Flu Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Human Injection Flu Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Human Injection Flu Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Human Injection Flu Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Human Injection Flu Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Human Injection Flu Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Human Injection Flu Vaccine Market Share Forecast by Application (2026-2035)
